This product is no longer in stock
Erivedge inhibits the hedgehog pathway and is used to treat adults with metastatic basal cell carcinoma. Erivedge is also used in patients with advanced local basal cell carcinoma recurring after surgery or in patients with this condition that are not eligible for surgery or radiation.
There are no contraindications for Erivedge.
Common side effects of Erivedge occurred in at least 10% of patients and include fatigue, alopecia, weight loss, vomiting, nausea, decreased appetite, diarrhea, constipation, ageusia, arthralgias, muscle spasms, and dysgeusia.
Roche Pharmaceuticals Ltd., Israel
Also known as: Vismodegib